Sjögren M - Search Results

1

Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients.

Olsson A, Höglund K, Sjögren M, Andreasen N, Minthon L, Lannfelt L, Buerger K, Möller HJ, Hampel H, Davidsson P, Blennow K. Olsson A, et al. Among authors: sjogren m. Exp Neurol. 2003 Sep;183(1):74-80. doi: 10.1016/s0014-4886(03)00027-x. Exp Neurol. 2003. PMID: 12957490 Clinical Trial.

2

Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms.

Sjögren M, Davidsson P, Wallin A, Granérus AK, Grundström E, Askmark H, Vanmechelen E, Blennow K. Sjögren M, et al. Dement Geriatr Cogn Disord. 2002;13(2):112-8. doi: 10.1159/000048642. Dement Geriatr Cogn Disord. 2002. PMID: 11844893

3

Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients.

Davidsson P, Westman-Brinkmalm A, Nilsson CL, Lindbjer M, Paulson L, Andreasen N, Sjögren M, Blennow K. Davidsson P, et al. Among authors: sjogren m. Neuroreport. 2002 Apr 16;13(5):611-5. doi: 10.1097/00001756-200204160-00015. Neuroreport. 2002. PMID: 11973456

4

Treatment with simvastatin in patients with Alzheimer's disease lowers both alpha- and beta-cleaved amyloid precursor protein.

Sjögren M, Gustafsson K, Syversen S, Olsson A, Edman A, Davidsson P, Wallin A, Blennow K. Sjögren M, et al. Dement Geriatr Cogn Disord. 2003;16(1):25-30. doi: 10.1159/000069989. Dement Geriatr Cogn Disord. 2003. PMID: 12714796 Clinical Trial.

5

Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers.

Sjögren M, Andreasen N, Blennow K. Sjögren M, et al. Clin Chim Acta. 2003 Jun;332(1-2):1-10. doi: 10.1016/s0009-8981(03)00121-9. Clin Chim Acta. 2003. PMID: 12763273 Review.

6

Decreased cerebrospinal fluid acetylcholinesterase in patients with subcortical ischemic vascular dementia.

Wallin A, Sjögren M, Blennow K, Davidsson P. Wallin A, et al. Among authors: sjogren m. Dement Geriatr Cogn Disord. 2003;16(4):200-7. doi: 10.1159/000072803. Dement Geriatr Cogn Disord. 2003. PMID: 14512714

7

The link between cholesterol and Alzheimer's disease.

Sjögren M, Blennow K. Sjögren M, et al. World J Biol Psychiatry. 2005;6(2):85-97. doi: 10.1080/15622970510029795. World J Biol Psychiatry. 2005. PMID: 16156481 Review.

8

Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia.

Tarkowski E, Issa R, Sjögren M, Wallin A, Blennow K, Tarkowski A, Kumar P. Tarkowski E, et al. Among authors: sjogren m. Neurobiol Aging. 2002 Mar-Apr;23(2):237-43. doi: 10.1016/s0197-4580(01)00285-8. Neurobiol Aging. 2002. PMID: 11804709

9

Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins.

Davidsson P, Sjögren M, Andreasen N, Lindbjer M, Nilsson CL, Westman-Brinkmalm A, Blennow K. Davidsson P, et al. Among authors: sjogren m. Brain Res Mol Brain Res. 2002 Dec 30;109(1-2):128-33. doi: 10.1016/s0169-328x(02)00549-1. Brain Res Mol Brain Res. 2002. PMID: 12531522

10

CSF markers for Alzheimer's disease: total tau, phospho-tau and Abeta42.

Andreasen N, Sjögren M, Blennow K. Andreasen N, et al. Among authors: sjogren m. World J Biol Psychiatry. 2003 Oct;4(4):147-55. doi: 10.1080/15622970310029912. World J Biol Psychiatry. 2003. PMID: 14608585 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

291 results

Search Page

Filters